Bladder Cancer: Offering Latest Technologies | Loyola Medicine

COVID-19 (Coronavirus) Update

Loyola Medicine is resuming select health care services. Learn more about resumption of services.

Friday, August 10, 2018

Loyola Offering Latest Technologies to Treat Bladder Cancer

Patient forms used by a doctor.
MAYWOOD, IL – Loyola Medicine uses the latest technologies to diagnose and treat bladder cancer, the fourth most common cancer in men.
Each year in the United States, about 80,000 new cases of bladder cancer are diagnosed. About 90 percent of cases are urothelial carcinomas – cancers that start in the urothelial cells that line the inside of the bladder. The most common risk factor is smoking.
At Loyola, bladder cancer is treated by an integrated team of experts including, medical oncologistsradiation oncologists and urologists. Loyola offers the full spectrum of treatments for every stage of bladder cancer, including radical cystectomy (removal of the bladder and lymph nodes). Loyola offers both robotic surgery and traditional open surgery.
Loyola’s department of urology has a strong track record of conducting clinical trials and translational research in urologic oncology. Loyola urologists perform more than 100 radical cystectomies per year and are thought leaders in the field.
Three Loyola urologists, Marcus Quek, MDGopal Gupta, MD, and Alex Gorbonos, MD, are co-authors of a recent landmark study that found that robotic surgery is as effective as traditional open surgery in treating bladder cancer.
Loyola is among 15 centers that participated in the nationwide trial of 350 patients, who were randomly assigned to undergo robotic surgery or open surgery to remove cancerous bladders. After two years, there was no significant difference between the two groups in survival without disease progression. Robotic surgery was associated with less blood loss and shorter hospital stays, but longer surgeries. The study was published in the journal Lancet.
Three main techniques are used to replace the bladder: construct a new bladder (neobladder) from the patient's own intestine; create a pouch inside the body to act as an artificial bladder; or place a bag outside the body to collect urine.
In addition to offering both open and robotic radical cystectomies, Loyola surgeons perform all three bladder-replacement techniques. There are pros and cons to each surgical technique, and Loyola physicians help patients decide which option best fits their lifestyle and health status.
“Loyola has become a center of excellence for bladder cancer care,” Dr. Quek said. “We offer a multidisciplinary approach to the treatment of our patients.”
Dr. Gupta added that working at Loyola “gives us the ability to see these patients, to treat them and to employ technology to better their outcomes and better their lives.”
Charles Clark, a patient of Dr. Gupta’s, is a good example. Five years after surgery, Mr. Clark remains active and cancer-free, with an excellent prognosis.
“The care at Loyola has been fantastic,” Mr. Clark said.
Mrs. Clark’s wife, Naomi Clark, said Mr. Clark’s treatments have given her great faith in Loyola. “They will help you there, not only physically, but spiritually,” she said.

About Loyola Medicine

Loyola Medicine is a quaternary care system based in the western suburbs of Chicago that includes Loyola University Medical Center (LUMC) in Maywood, Gottlieb Memorial Hospital (GMH) in Melrose Park, MacNeal Hospital in Berwyn and convenient locations offering primary and specialty care services from more than 1,772 physicians throughout Cook, Will and DuPage counties. LUMC is a 547-licensed-bed hospital that includes the William G. and Mary A. Ryan Center for Heart & Vascular Medicine, the Cardinal Bernardin Cancer Center, a Level 1 trauma center, Illinois's largest burn center, a certified comprehensive stroke center and a children’s hospital. The medical center campus is also home to Loyola University Chicago Stritch School of Medicine, Loyola University Chicago Marcella Niehoff School of Nursing and the Loyola Center for Fitness. GMH is a 247-licensed-bed community hospital with 150 physician offices, an adult day care program, the Gottlieb Center for Fitness, the Loyola Center for Metabolic Surgery and Bariatric Care and the Loyola Cancer Care & Research at the Marjorie G. Weinberg Cancer Center at Melrose Park. MacNeal Hospital is a 374-bed teaching hospital with advanced inpatient and outpatient medical, surgical and psychiatric services, advanced diagnostics and treatments in a convenient community setting. Loyola Medicine is a member of Trinity Health, one of the nation’s largest health systems with 94 hospitals in 22 states.

About Trinity Health

Trinity Health is one of the largest multi-institutional Catholic health care delivery systems in the nation, serving diverse communities that include more than 30 million people across 22 states. Trinity Health includes 93 hospitals, as well as 122 continuing care programs that include PACE, senior living facilities, and home care and hospice services. Its continuing care programs provide nearly 2.5 million visits annually. Based in Livonia, Mich., and with annual operating revenues of $17.6 billion and assets of $23.4 billion, the organization returns $1.1 billion to its communities annually in the form of charity care and other community benefit programs. Trinity Health employs about 131,000 colleagues, including 7,500 employed physicians and clinicians. Committed to those who are poor and underserved in its communities, Trinity Health is known for its focus on the country's aging population. As a single, unified ministry, the organization is the innovator of Senior Emergency Departments, the largest not-for-profit provider of home health care services — ranked by number of visits — in the nation, as well as the nation’s leading provider of PACE (Program of All Inclusive Care for the Elderly) based on the number of available programs. For more information, visit You can also follow @TrinityHealthMI on Twitter.